Heart pump devices market seen reaching $10.37 billion by 2030

The heart pump devices market is projected to nearly double from 2025 to 2030 as cardiovascular disease rates rise and demand grows for longer-term circulatory support. North America led the market in 2025, while new monitoring and minimally invasive technologies are shaping future growth.

Why it matters: - The heart pump devices market is scaling as hospitals and cardiac care teams need more support tools for heart failure, surgery and high-risk procedures. - The market is projected to grow from $4.48 billion in 2025 to $10.37 billion by 2030. - Rising cardiovascular disease adds pressure on healthcare systems and increases demand for mechanical circulatory support.

What happened: - The Business Research Company released a market report on heart pump devices on Aug. 10, 2026. - The report says the market will reach $5.32 billion in 2026, up from $4.48 billion in 2025. - The report projects a 19.0% CAGR from 2025 to 2026 and an 18.1% CAGR from 2026 to 2030. - North America held the largest share of the heart pump devices market in 2025. - The report covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample is available through the company’s sample request page. - The full report is available through the company’s market report page.

The details: - Heart pump devices are mechanical support systems that help pump blood from the heart chambers to the rest of the body. - These devices provide temporary support during cardiac distress or surgical intervention. - Growth in the market has been driven by higher heart failure incidence, more cardiac surgery programs, better mechanical pump technology, longer transplant waiting lists and wider use of extracorporeal support systems. - Future growth is tied to demand for long-term circulatory support, destination therapy devices, minimally invasive cardiac procedures, smart monitoring technologies and higher investment in advanced cardiac care. - Key trends include broader use of ventricular assist devices, more temporary mechanical circulatory support, miniaturized implantable pumps, bridge-to-transplant therapies and improved hemodynamic performance monitoring. - The American Heart Association said the age-adjusted US cardiovascular disease death rate rose to 233.3 per 100,000 in 2024 from 224.4 per 100,000 in 2023. - The report also says updated 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics and future trend analysis.

Between the lines: - The market outlook points to a shift from short-term emergency support toward more durable and data-enabled cardiac devices. - The combination of aging populations, higher disease burden and longer transplant waits is widening the need for both temporary and long-term solutions. - North America’s lead suggests the region remains an early adopter of advanced cardiac technologies.

What's next: - The market is expected to keep expanding toward 2030 as smart monitoring and minimally invasive systems gain adoption. - Product development is likely to focus on smaller implantable devices and more integrated performance monitoring. - The company is directing readers to more information and its sample report for additional data.